What is Alexandria Real Estate Equities?
Life science REIT with life science real estate platform with 2025 revenue of about $3.0B.
- Category
- Life science REIT
- Headquarters
- Pasadena, CA
- Founded
- 1994
- Employees
- Approximately 570
- Total funding
- Public company; NYSE: ARE; no VC funding profile
- Status
- NYSE: ARE; public company
What is Alexandria Real Estate Equities?
Alexandria Real Estate Equities is a public life science reit headquartered in Pasadena, CA. Its current public-company scale signal is life science real estate platform with 2025 revenue of about $3.0B.
Alexandria Real Estate Equities is a public life science reit headquartered in Pasadena, CA. The company operates collaborative life science megacampuses and research buildings in Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, New York City, and Research Triangle, and its latest public reporting shows life science real estate platform with 2025 revenue of about $3.0B. That makes it an enterprise-scale real estate account rather than a single-property operator.
The business serves tenants, residents, operators, carriers, consumers, or homebuyers through a mix of physical assets, digital leasing or sales channels, local operating teams, and centralized finance and technology functions. Its market position is shaped by asset quality, cost of capital, operating execution, tenant or customer retention, and disciplined capital allocation.
For B2B sellers, Alexandria Real Estate Equities should be mapped by business unit and asset workflow. The strongest opportunities attach to measurable outcomes: leasing velocity, occupancy, retention, construction cycle time, procurement savings, risk reduction, uptime, resident or customer experience, data quality, and compliance.
What does Alexandria Real Estate Equities offer?
Alexandria Real Estate Equities offers Life science laboratory space, Megacampuses, Office/lab leasing, Development, Redevelopment and related real estate services.
- Life science laboratory space· Offering
- Megacampuses· Offering
- Office/lab leasing· Offering
- Development· Offering
- Redevelopment· Offering
- Tenant venture investments· Offering
- Amenity ecosystems· Offering
How does Alexandria Real Estate Equities make money?
Alexandria Real Estate Equities makes money through lab and office rent, long-term leases to life science and technology tenants, development value creation, redevelopment, and strategic venture investments.
Alexandria Real Estate Equities makes money through lab and office rent, long-term leases to life science and technology tenants, development value creation, redevelopment, and strategic venture investments. lab rents are negotiated by market, building, lab buildout, term, tenant credit, and TI package; economics are leasing spreads, occupancy, development yields, NOI, and FFO. Because it is a public company, the most reliable unit-economic signals are revenue, NOI or gross margin, occupancy or closings, FFO/AFFO where relevant, backlog, leasing spreads, and capital allocation disclosures.
Growth is driven by pricing, volume, retention, development or acquisition spreads, cost of capital, operating efficiency, and the company's ability to deploy capital into assets or communities with durable demand. In a higher-rate environment, management quality and balance-sheet discipline matter as much as headline revenue growth.
For vendors, budget is usually unlocked when a product improves a metric the company already reports to investors: faster leasing, better resident or tenant experience, lower maintenance cost, more efficient construction, safer field operations, stronger cybersecurity, cleaner data, or better capital planning.
Who leads Alexandria Real Estate Equities?
Alexandria Real Estate Equities is led by Peter M. Moglia, Chief Executive Officer, with finance, operations, investment, and technology leaders shaping major buying decisions.
- Peter M. MogliaChief Executive OfficerCEO since 2024Leads operating execution and portfolio strategy.
- Joel S. MarcusExecutive Chairman and FounderFounder since 1994Sets long-term life science cluster strategy and relationships.
- Dean A. ShigenagaPresident and Chief Financial OfficerLongtime finance leaderOwns finance, capital markets, and investor communication.
- Jennifer BanksCo-Chief Operating Officer and General CounselSenior executive teamLeads legal, operations, and governance functions.
How do you contact Alexandria Real Estate Equities's leadership?
Alexandria Real Estate Equities publishes official investor, media, customer, or corporate contact routes, but the reviewed sources do not establish personal executive email addresses as the official way to reach leaders. Use the public company route here and treat any inferred personal address as unverified unless the company publishes it.
Personal executive email format not verified; use https://investor.are.com/corporate-profile/default.aspx- Dean A. ShigenagaPresident and Chief Financial Officerhttps://investor.are.com/corporate-profile/default.aspx
- Investor relationsPublic-company investor contacthttps://investor.are.com/corporate-profile/default.aspx
How much funding has Alexandria Real Estate Equities raised?
Alexandria Real Estate Equities is a public company (NYSE: ARE) and is not best described by venture funding raised.
Alexandria Real Estate Equities is a mature public company, not a venture-backed startup with seed, Series A, or late-stage private financing rounds. Its relevant capital profile is public equity, unsecured debt or mortgage debt, operating cash flow, asset sales, acquisitions, dividends, and share repurchases rather than VC funding.
The major capital milestones are: 1994 Founded (Alexandria is founded to build life science real estate clusters.); 1997 IPO (The company becomes the first publicly traded urban office/lab REIT.); 2000s Cluster strategy scales (The company deepens campuses in core innovation markets.); 2024 CEO transition (Peter Moglia becomes CEO while founder Joel Marcus remains Executive Chairman.); 2025 $3.0B revenue year (The company reports about $3.0B in annual revenue.); 2026 Q1 leasing pipeline (Operating metrics show leased temporary vacancies expected to occupy after improvements.). As of June 2026, the most useful buyer signal is not a private valuation but 2025 annual revenue of about $3.0B, NYSE: ARE, and the scale of its asset base and capital program.
For sellers, that means buying capacity exists but is governed by mature procurement, IT, legal, compliance, finance, and asset-level operating review. The winning case ties directly to revenue, occupancy, leasing, closings, maintenance, risk, uptime, data, or operating-cost metrics.
How did Alexandria Real Estate Equities get here?
Alexandria Real Estate Equities scaled through public-market capital, portfolio operations, and disciplined real estate or homebuilding execution.
- 1994Company foundedAlexandria begins focusing on life science real estate.
- 1997Public listingThe company lists on the NYSE.
- 2010sMegacampus modelClusters in Boston, San Diego, Seattle, and the Bay Area deepen.
- 2024Moglia named CEOLeadership transition keeps founder involved as Executive Chairman.
- 20252025 annual report filedThe company reports through a difficult life science real estate cycle.
- 2026Q1 operating updatesManagement reports expected revenue from leased temporary vacancies.
Who are Alexandria Real Estate Equities's competitors?
Alexandria Real Estate Equities competes with public and private operators that target the same property type, customer base, capital sources, and operating talent.
- BioMed RealtyPrivate life science real estate owner
- Healthpeak PropertiesPublic health care and life science REIT
- Breakthrough PropertiesLife science real estate developer backed by Tishman Speyer and Bellco
- Longfellow Real Estate PartnersLife science real estate developer and operator
- BXPPremier office and life science landlord
Alexandria Real Estate Equities — frequently asked questions
